Ikena Oncology shareholders elect three Class I directors and ratify EY as auditor

ImageneBio, Inc.

Elected Iain D. Dukes (23.9M for), Maria Koehler (24.6M for), Otello Stampacchia (23.3M for) to 3-year terms.
Ratified Ernst & Young as independent auditor for FY 2022 with 28.5M votes for, 1,095 against.
Meeting held June 9, 2022; all stockholder proposals passed.

item 5.07

ImageneBio, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-171517

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.